Seneca S, Lissens W
Department of Medical Genetics, University Hospital-Vrije, Brussels, Belgium.
J Inherit Metab Dis. 1995;18 Suppl 1:34-44. doi: 10.1007/BF00711427.
The X-linked adrenoleukodystrophy (ALD) gene was identified recently and is predicted to encode a 745-amino-acid peroxisomal membrane protein. Strategies have been designed for the search for mutations in the ALD gene in patients. Several mutations have now been found and it seems that many different mutations are responsible for ALD. There is no straightforward correlation between genotype and phenotype since the same mutation can cause different ALD phenotypes in the same family. However, once a mutation has been found in a family, it can be traced in all at-risk individuals of that family, both post- and prenatally, without the need for very long-chain fatty acid (VLCFA) analysis. Segregation analysis with extragenic and intragenic polymorphisms may remain useful in families where mutation analysis is not possible for practical reasons; VLCFA analysis and measurement of the peroxisomal beta-oxidation with C26:0 fatty acid as a substrate will remain the alternative. We also briefly discuss the possibilities of DNA diagnosis for other peroxisomal disorders.
X连锁肾上腺脑白质营养不良(ALD)基因最近已被鉴定出来,预计它编码一种含745个氨基酸的过氧化物酶体膜蛋白。现已设计出在患者中寻找ALD基因突变的策略。目前已发现了几种突变,似乎许多不同的突变都与ALD有关。基因型与表型之间没有直接的相关性,因为同一突变在同一家族中可导致不同的ALD表型。然而,一旦在一个家族中发现了突变,就可以在该家族所有有患病风险的个体中进行追踪,无论是产后还是产前,而无需进行极长链脂肪酸(VLCFA)分析。对于因实际原因无法进行突变分析的家族,与基因外和基因内多态性的连锁分析可能仍然有用;VLCFA分析以及以C26:0脂肪酸为底物的过氧化物酶体β氧化的测定仍将是替代方法。我们还简要讨论了对其他过氧化物酶体疾病进行DNA诊断的可能性。